Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey Article

Salami, Joseph A, Valero-Elizondo, Javier, Ogunmoroti, Oluseye et al. (2017). Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey . 6(6), 10.1161/JAHA.116.004996

Open Access

cited authors

  • Salami, Joseph A; Valero-Elizondo, Javier; Ogunmoroti, Oluseye; Spatz, Erica S; Rana, Jamal S; Virani, Salim S; Blankstein, Ron; Younus, Adnan; Arrieta, Alejandro; Blaha, Michael J; Veledar, Emir; Nasir, Khurram

sustainable development goals

authors

publication date

  • June 1, 2017

webpage

keywords

  • BURDEN
  • COMORBIDITY
  • COST
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • HEALTH
  • HYPERTENSION
  • IMPACT
  • Life Sciences & Biomedicine
  • OBESITY
  • Science & Technology
  • coronary heart disease
  • cost
  • modifiable risk factors
  • pharmaceutical expenditure

Digital Object Identifier (DOI)

publisher

  • WILEY

volume

  • 6

issue

  • 6